📖

NURR1 Gene

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-nurr1

Related Entities

Metadata

slug	genes-nurr1
entity_type	gene
kg_node_id	NURR1

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (157)

mentions🧪Programmable Neuronal Circuit Repair via Epigenetic CRISPR90%

related🧪Programmable Neuronal Circuit Repair via Epigenetic CRISPR90%

see_also🧪Programmable Neuronal Circuit Repair via Epigenetic CRISPR70%

see_also📖AMPK (AMP-Activated Protein Kinase)60%

see_also📖entities-gdnf60%

see_also📖Autophagy Enhancement Drug Screening for Neurodegeneration60%

see_also📖ASCL1 Gene60%

see_also📖BDNF Gene60%

see_also📖FGFR1 — Fibroblast Growth Factor Receptor 160%

see_also📖lmx1a60%

see_also📖VMAT2 Gene60%

see_also📖Packard Center for ALS Research60%

see_also📖Aging vs Neurodegeneration: Mechanistic Comparison Matrix60%

see_also📖CREB-independent Neuronal Survival Pathways60%

see_also📖lmx1b60%

see_also📖CREB1 Gene60%

see_also📖DMPK Gene (Dystrophia Myotonica Protein Kinase)60%

see_also📖entities-gba60%

see_also📖PITX3 Gene60%

see_also📖4D Molecular Therapeutics60%

see_also📖Alzheimer's Digital Therapeutics Companies60%

see_also📖AD Exosome and Extracellular Vesicle Companies60%

see_also📖AD RNA-Based Therapeutics Companies60%

see_also📖Alectos Therapeutics Inc60%

see_also📖Aleza Therapeutics60%

see_also📖Alterity Therapeutics60%

see_also📖Amyl Therapeutics60%

see_also📖Appvian Therapeutics60%

see_also📖Arvinas Therapeutics60%

see_also📖Axial Therapeutics60%

see_also📖Axsome Therapeutics, Inc.60%

see_also📖BlueRock Therapeutics60%

see_also📖BrainStorm Cell Therapeutics Inc.60%

see_also📖Capricor Therapeutics60%

see_also📖Cerevel Therapeutics60%

see_also📖Chelsea Therapeutics60%

see_also📖Click Therapeutics60%

see_also📖Convelo Therapeutics60%

see_also📖CRISPR Therapeutics60%

see_also📖cyclo-therapeutics60%

see_also📖cynata-therapeutics60%

see_also📖Cytochrome Therapeutics60%

see_also📖Denali Therapeutics60%

see_also📖Encoded Therapeutics60%

see_also📖Evox Therapeutics60%

see_also📖Finch Therapeutics60%

see_also📖Fulcrum Therapeutics60%

see_also📖heqIX Therapeutics60%

see_also📖Iduna Therapeutics60%

see_also📖IFM Therapeutics60%

see_also📖Inception Therapeutics60%

see_also📖Karuna Therapeutics60%

see_also📖Koneqia Therapeutics60%

see_also📖Lexeo Therapeutics60%

see_also📖Lysoway Therapeutics60%

see_also📖Lyterian Therapeutics60%

see_also📖Monte Rosa Therapeutics60%

see_also📖Muna Therapeutics60%

see_also📖Neteo Therapeutics60%

see_also📖NeuBase Therapeutics60%

see_also📖NeuExo Therapeutics60%

see_also📖Neumora Therapeutics60%

see_also📖NeuroMito Therapeutics60%

see_also📖Paxos Therapeutics60%

see_also📖Parkinson's Disease Digital Therapeutics Companies60%

see_also📖pd-exosome-therapeutics60%

see_also📖PD RNA Therapeutics Companies60%

see_also📖Pear Therapeutics60%

see_also📖Pinteon Therapeutics60%

see_also📖Prevail Therapeutics60%

see_also📖Rodin Therapeutics60%

see_also📖Sage Therapeutics60%

see_also📖Sangamo Therapeutics60%

see_also📖Spark Therapeutics60%

see_also📖Spin Therapeutics60%

see_also📖Stoke Therapeutics60%

see_also📖Synaptic Therapeutics60%

see_also📖Synchronicity Therapeutics60%

see_also📖T3D Therapeutics60%

see_also📖Trefoil Therapeutics60%

see_also📖Vator Therapeutics Inc.60%

see_also📖Ventus Therapeutics60%

see_also📖Voyager Therapeutics60%

see_also📖VTV Therapeutics60%

see_also📖Yumanity Therapeutics60%

see_also📖MDS 2026 — Emerging Therapeutics in Parkinson's Disease60%

see_also📖Aleza Therapeutics60%

see_also📖Denali Therapeutics60%

see_also📖4R Tauopathy Therapeutics — Investment Landscape Analysis60%

see_also📖Adult Neurogenesis Therapeutics Investment Landscape60%

see_also📖Anti-Tau Therapeutics: Investment Landscape Analysis60%

see_also📖ER Stress & UPR Therapeutics Investment Landscape60%

see_also📖GLP-1 Receptor Agonist Therapeutics Investment Landscape60%

see_also📖Heat Shock Protein (HSP) Therapeutics for Neurodegeneration60%

see_also📖Lysosomal Dysfunction Therapeutics Investment Landscape60%

see_also📖Microbiome-Based Therapeutics for Neurodegeneration: Investm60%

see_also📖Mitochondrial Therapeutics Investment Landscape60%

see_also📖Peptide Therapeutics for Neurodegeneration — Investment Land60%

see_also📖Protein Aggregation Inhibitors for Neurodegeneration — Inves60%

see_also📖RNA Therapeutics: Investment Landscape Analysis60%

see_also📖Senolytic Therapeutics: Investment Landscape Analysis60%

see_also📖Anti-Amyloid Therapeutics: Successes, Failures, and Lessons 60%

see_also📖Denali Therapeutics60%

see_also📖Digital Therapeutics for Neurodegenerative Diseases60%

see_also📖RNA Editing Therapeutics60%

see_also📖therapeutics60%

see_also📖Anti-Amyloid Therapeutics60%

see_also📖Anti-Tau Therapeutics60%

see_also📖Exosome-Based Therapeutics for Neurodegenerative Diseases60%

see_also📖Mitochondrial Therapeutics60%

see_also📖Neurotrophic Factor Therapies for Neurodegenerative Diseases60%

see_also📖TGF-beta Signaling Therapies for Neurodegeneration60%

see_also📖Neurofilament Medium Chain (NfM) - Biomarker60%

see_also📖nfm60%

see_also📖Neurofilament Medium Chain (NF-M)60%

see_also📖PGC-1α Protein60%

see_also📖PGC-1α (PPARGC1A)60%

mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di50%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

mentions🧪Competitive APOE4 Domain Stabilization Peptides50%

mentions🧪APOE Isoform Expression Across Glial Subtypes50%

mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%

mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming50%

mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%

mentions🧪Lysosomal Positioning Dynamics Modulation50%

mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%

mentions🧪The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction50%

mentions🧪TFEB-PGC1α Mitochondrial-Lysosomal Decoupling50%

mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis50%

mentions🧪CYP46A1 Overexpression Gene Therapy50%

mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%

related🔬What are the mechanisms underlying neuroinflammation resolut50%

related🔬Investigate how lipid raft composition (cholesterol metaboli50%

related🔬What are the mechanisms underlying neuroinflammation resolut50%

related🔬Investigate how lipid raft composition (cholesterol metaboli50%

related🔬Analyze circuit-level changes in neurodegeneration using All50%

related🔬CRISPR-based therapeutic approaches for neurodegenerative di50%

related🔬What are the mechanisms underlying apoe4 structural biology 50%

related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%

related🔬What are the mechanisms underlying epigenetic clocks and bio50%

mentions🔬Analyze circuit-level changes in neurodegeneration using All40%

related🧪Epigenetic Memory Reprogramming for Alzheimer's Disease40%

related🧪Trinucleotide Repeat Sequestration via CRISPR-Guided RNA Tar40%

related🧪Context-Dependent CRISPR Activation in Specific Neuronal Sub40%

related🧪Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci40%

related🧪Programmable Neuronal Circuit Repair via Epigenetic CRISPR40%

related🧪Cholesterol-CRISPR Convergence Therapy for Neurodegeneration40%

related🧪Multi-Modal CRISPR Platform for Simultaneous Editing and Mon40%

related🧪CYP46A1 Overexpression Gene Therapy40%

related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th40%

related🧪Context-Dependent CRISPR Activation in Specific Neuronal Sub40%

related🧪Multi-Modal CRISPR Platform for Simultaneous Editing and Mon40%

related🔬CRISPR-based therapeutic approaches for neurodegenerative di40%